Subscribe to Search results

The ACVSB felt that there was no case for using surrogate tests for Non-A Non-B Hepatitis.

Published on:

A report for a multi-centre study on Non-A Non-B Hepatitis surrogate screening was completed.

Published on:

Dr Kernoff wrote to Dr Colvin describing Non-A Non-B Hepatitis as "a serious disease with long-term consequences".

Published on:

Alter et al published a paper titled 'The Chronic Sequelae of Non-A Non-B Hepatitis B' in the Annals of Internal Medicine journal.

Published on:

A study by Ware et al titled 'Etiology of liver disease in renal transplant patients' reported that infection with NANBH accounted for much of serious, often fatal, complications of renal transplantation.

Published on:

In his written statement, Professor John Gillon noted that there was no doubt that screening with one or both of the the ALT or anti-HBc screening tests would have prevented some cases of NANBH, and in spite of the lack of data on the incidence of PTNANBH this would have been a desirable outcome.

Published on:

In a written submission to the Inquiry, SNBTS stated that they have on balance reached the conclusion that surrogate testing for NANBH should have been introduced.

Published on:

Alter et al wrote in the New England Journal of Medicine that 'surrogate assays for anti-HBc and alanine aminotransferase would have detected approximately half the anti-HCV-positive donors involved in the transmission of hepatitis they had identified.

Published on:

A study from Canada, published in the Lancet, found that 70 percent of hepatitis C infections would have been avoided by the use of the two surrogate markers, ALT and anti HBc.

Published on:

Journal article titled 'The Chronic Sequelae of Non-A Non-B Hepatitis B' described chronic NANBH as symptomatically mild and unaccompanied by physical signs or laboratory evidence of autoimmune disease or severe chronic liver disease..

Published on:

A report on NANB Hepatitis was prepared for the ACVSB. It described the issue of surrogate testing for NANBH as being "of some urgency" and suggested that it be a major item for the next meeting.

Published on:

Alter et al published a paper titled 'The Chronic Sequelae of Non-A Non-B Hepatitis B' in the Annals of Internal Medicine journal.

Published on:

The maximum pool size at BPL increased to 5,000 donations.

Published on:

Capacity to accommodate larger pool sizes increased at PFC.

Published on:

Maximum pool sizes at BPL increased to 7,500 donations.

Published on:

Maximum pool sizes at BPL increased to 10,000 donations.

Published on:

A blood donor diagnosed with AIDS at Bournemouth Hospital.

Published on:

The CMO publicly confirmed that the donations of a blood donor, who had been diagnosed with AIDs, had been traced.

Published on:

The regional transfusion directors agreed that the blood services would make the initial approach to a donor where a positive donation was found.

Published on:

At the EAGA meeting, Dr Contreras said AIDS patients should be asked if they had donated blood in the last five years.

Published on: